Trial intelligence / Profile preview

Adjunct dexmedetomidine loading dose with propofol-based sedation to reduce hypoxia during ERCP

TCTR20250914006Phase 4Recruiting

Sponsor
Research and Innovation Affairs
Start
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in None, sponsored by Research and Innovation Affairs. Started Sep 2025; status: recruiting.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on TCTR20250914006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250914006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call